chemotherapy 3 - Throat Cancer Foundation

Major Breakthrough: Immunotherapy Doubles Remission Time

June 2, 2025

A significant advancement in treating head and neck cancers, including throat cancer, has emerged from the international phase III KEYNOTE-689 trial. The study demonstrated that administering the immunotherapy drug pembrolizumab (Keytruda) both before and after surgery, alongside standard treatments like radiotherapy and chemotherapy, extended the average cancer-free period from 2.5 years to 5 years. This

Taking on The Wall: Andi Woolass’s 70-Mile Challenge for Throat Cancer Awareness

May 31, 2025

When it comes to fundraising, few challenges are as physically and emotionally demanding as The Wall ultramarathon. Yet, for Andi Woolass, the 70-mile trek from Carlisle Castle to Gateshead’s Baltic Quay is more than just a test of endurance—it’s a deeply personal mission to raise awareness and funds for the Throat Cancer Foundation. A Personal

The UK’s Newest Charity

January 29, 2013

Archive note: This was the Throat Cancer Foundation’s first website post, published in January 2013. We have kept it as part of our history, marking the moment the charity began giving a stronger voice to people affected by throat cancers. A brand new charity The UK has a new charity, and it is already beginning